A critical discovery in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently inactivated in many forms of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research